(redirected from cervical intraepithelial neoplasia)
Also found in: Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.


1. Formation of new tissue.
2. Formation of a neoplasm or neoplasms.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.


(Medicine) an abnormal growth of tissue, the development of a neoplasm, or the process that results in the production of a neoplasm or tumour
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014


(ˌni oʊˈpleɪ ʒə, -ʒi ə, -zi ə)

the formation and growth of neoplasms.
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.


the abnormal proliferation of benign or malignant cells. — neoplastic, adj.
See also: Cancer
the growth or formation of a neoplasm. — neoplastic, adj.
See also: Growth
the growth or formation of aneoplasm. — neoplastic, adj.
See also: Body, Human
-Ologies & -Isms. Copyright 2008 The Gale Group, Inc. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.neoplasia - the pathological process that results in the formation and growth of a tumor
pathologic process, pathological process - an organic process occurring as a consequence of disease
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.


n. neoplasia, formación de neoplasmas.
English-Spanish Medical Dictionary © Farlex 2012


n neoplasia (proceso)
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
Adverse pregnancy outcomes after treatment for cervical intraepithelial neoplasia. BMJ 2008;337:a1350.
The analysis showed an adjusted excess hazard for developing cervical intraepithelial neoplasia (CIN) I of 53%, compared with the general population, and an excess 39% rate of CIN II or III, both statistically significant differences, Dr.
Cervical intraepithelial neoplasia included all cases of CIN 1, CIN 2 and CIN 3.
Risk of cervical intraepithelial neoplasia grade 2 or 3 after loop electrosurgical excision procedure associated with human papillomavirus type 16 variants.
Lower red blood cell folate enhances the HPV-16-associated risk of cervical intraepithelial neoplasia. Nutrition.
Abivalent vaccine for human papillomavirus manufactured by GlaxoSmithKline has shown greater than 90% efficacy against high-grade cervical intraepithelial neoplasia, according to interim results from a large, randomized controlled trial published online in the Lancet.
A literature search of Medline and the Cochrane libraries found 15 articles on the rate of recurrence of cervical intraepithelial neoplasia (CIN) in HIV-positive women after excision of affected tissue and a margin of normal tissue.
TABLE Strategies for managing CIN1 FOLLOW-UP/ INTERVENTION SENSITIVITY FOR REFERRAL RATE AFTER DIAGNOSIS OF CIN1 DETECTING FOR REPEAT AT COLPOSCOPY CIN1 OR HIGHER COLPOSCOPY hr-HPV test at 12 months 92.2% 55% hr-HPV test at 6 months 90.9% 62.4% Cytology at 6 and 12 months 85% 60% Cytology at 6, 12, 18 months 95% Not available hr-HPV test and cytology 94.8% 64.1% at 12 months CIN1, cervical intraepithelial neoplasia grade 1; hr-HPV, high-risk subtypes of human papillomavirus.
According to the company, GX-188E is a HPV therapeutic DNA vaccine for cervical intraepithelial neoplasia (CIN) and HPV-induced cancers caused by persistent infection by high-risk HPV types, 16/18.
Endocervical gland involvement by cervical intraepithelial neoplasia grade III.
(2) Histopathologic results remain a key foundation of cervical screening efforts in the United States, and biopsy diagnoses of cervical intraepithelial neoplasia (CIN) 2 or worse represent the clinical threshold leading to ablative or excisional therapy.
LOS ANGELES -- An investigational type of photodynamic therapy appears promising for treating early cervical intraepithelial neoplasia, finds a phase 2b trial reported at the annual meeting of the Society of Gynecologic Oncology.

Full browser ?